SP

Samuel Scott Panter

HF Healthpartners Research Foundation: 12 patents #2 of 25Top 8%
BF Biomedical Frontiers: 2 patents #3 of 8Top 40%
HI Healthpartners Institute: 1 patents #5 of 9Top 60%
📍 San Francisco, CA: #2,827 of 26,999 inventorsTop 15%
🗺 California: #40,325 of 386,348 inventorsTop 15%
Overall (All Time): #322,086 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDate
9801835 Method of pre-treating patients for stroke comprising administering metal chelators to the upper one-third of the nasal cavity William H. Frey, II, Leah Ranae Bresin Hanson 2017-10-31
9707193 Method of treating cerebral hemorrhage and subarachnoid hemorrhage comprising administering metal chelators to the upper one-third of the nasal cavity William H. Frey, II, Leah Ranae Bresin Hanson 2017-07-18
9636313 Method of treating spinal cord injury comprising administering metal chelators to the upper one-third of the nasal cavity William H. Frey, II, Leah Ranae Bresin Hanson 2017-05-02
9636312 Method of treating traumatic brain injury/head injury comprising administering metal chelators to the upper one-third of the nasal cavity William H. Frey, II, Leah Ranae Bresin Hanson 2017-05-02
9629819 Method of treating progressive supranuclear palsy comprising administering metal chelators to the upper one-third of the nasal cavity William H. Frey, II, Leah Ranae Bresin Hanson 2017-04-25
9351927 Pharmaceutical compositions for treatment of patients with neurodegeneration following ischemic insult William H. Frey, II, Leah Ranae Bresin Hanson, Annina Roeytenberg 2016-05-31
9345676 Method of treating stroke comprising administering metal chelators to the upper one-third of the nasal cavity William H. Frey, II, Leah Ranae Bresin Hanson 2016-05-24
9216161 Methods of treating Huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavity William H. Frey, II, Leah Ranae Bresin Hanson 2015-12-22
9211272 Method of treating lewy body syndrome comprising administering metal chelators to the upper one-third of the nasal cavity William H. Frey, II, Leah Ranae Bresin Hanson 2015-12-15
9211273 Methods of treating neurodegeneration caused by iron accumulation in the brain comprising administering metal chelators to the upper one-third of the nasal cavity William H. Frey, II, Leah Ranae Bresin Hanson 2015-12-15
9205066 Method of treating parkinson's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity Leah Ranae Bresin Hanson, William H. Frey, II 2015-12-08
8568691 Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning William H. Frey, II, Leah Ranae Bresin Hanson 2013-10-29
7776312 Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity William H. Frey, II, Leah Ranae Bresin Hanson, Annina Roeytenberg 2010-08-17
5217998 Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid Bo E. Hedlund, Philip E. Hallaway, John W. Eaton 1993-06-08
4863964 Method for the stabilization of deferoxamine to chelate free ions in physiological fluid Bo E. Hedlund, Philip E. Hallaway, John W. Eaton 1989-09-05